Acumen Research and Consulting, a global provider of market research studies, in a latest published report titled “Platelet and Plasma Market, Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 – 2028”
The global platelet and plasma market is expected to reach the market value of around US$ 8.1 Bn by 2028 and is anticipated to grow at a CAGR of around 3.4% in terms of revenue during the forecast period 2021 – 2028.
North America platelet and plasma accounted for the highest profits in 2019 and is projected in the forecast timeframe to rise at a substantial pace. Growing cases of cancer, obesity, heart disease, neurological disorders, and other chronic diseases are a consequence of their development. In turn, the U.S. Red Cross undertakes numerous campaigns to increase awareness about the value about blood donation. North American blood donor programs are based around a hybrid program of both non-compensated and combined contributions. However, the growing demand for new technologies and the development of modern health services would accelerate regional growth during the projected period.
Download Sample Pages Of This Study@ https://www.acumenresearchandconsulting.com/request-sample/2162
The growth of the plasma market in Europe over the forecasting period will be powered by rising blood transfusion levels. The method of blood transfusion is primarily used to separate blood components such as red blood cells, serum, platelets, or other essential blood components. Public awareness-raising programs for the production of source plasma and the application of plasma-saving treatments of unusual diseases would have a positive impact on consumer development. The rise of the platelet and plasma market will have a significant impact in coming years as health infrastructure grows combined with the rising number of blood transfusions. Some other major driver for market development is the introduction of technically innovative platelet and plasma products. Treating rare, declining, life-threatening, and chronic diseases through the use of platelets and plasma significantly affects the success of the market. Blood-derived plasma can be used for the treatment of genetic conditions without any additional testing. During the Ebola virus situation, plasma treatment is used in West Africa to recover the present from the Ebola virus. Over the forecast period, trends would accelerate market growth.
View Table Of Content Of This Study@ https://www.acumenresearchandconsulting.com/platelet-and-plasma-market
During the forecast period, the platelet segment was the largest market share and will continue to dominate in the sector. That is due to the new methods for treating various illnesses are gradually being implemented. Owing to its detailed medical and prophylactic uses, platelets are used in numerous surgical procedures. In 2016, about 2,95,866 individuals were suffering from bleeding problems, 1,84,723 of which were hemophilia, as the World Haemophilia Federation (WFH) reported. The rising need for platelets for hemophilia care and other blood disorders would drive development in the segment over the forecast. In turn, numerous policy programs and other organizations will further fuel demand for the sector in order to facilitate human blood donation and the implementation of emerging technology in developed and growing economies.
Ambulatory surgical centers segment is projected to show a robust growth trajectory
The segment of the ambulatory surgical centers, owing to the growing demand for outpatient procedures, was valued at around USD 1.7 billion in 2019. Various benefits, including inexpensive clinical care and the elimination of the risk of hospital transmitted illness, improve the patient demand for outpatient centers. In turn, improved awareness of platelet and plasma therapy in the outpatient clinics would further boost the demand.
The global platelet and plasma market includes prominent players such as American Red Cross, America’s Blood Centres, Spanish Red Cross, Blood Centres of America, European Blood Alliance, Japanese Red Cross Society, Red Cross Society of China, Indian Red Cross Society, Saudi Red, Crescent Authority, Arthrex, Inc., South Africa Red Cross Society., AdiStem Ltd., and others. The notable market participants are strategically implementing several business strategies to increase the awareness among people pertaining to blood donation in order to meet the demand for platelet and plasma.
Browse Upcoming Market Research Study@ https://www.acumenresearchandconsulting.com/forthcoming-reports
- In April 2020OneBlood, a non-profit blood bank launched platelet and plasma donations from patients treating coronavirus after the COVID-19 pandemic. The plasma obtained is passed to patients suffering from COVID-19 and helps them recover. The successful presence of the organization would contribute to its business production.
- In April 2019, OneBlood merged with Carolinas Inc’s Collective Blood Centre. This partnership led to the sale of over one million blood products in over 250 hospitals throughout South Carolina, North Carolina, Alabama, and Georgia.
- In April 2018, the redesigned RedCrossBlood.org was restarted by the American Red Cross. This strategy has improved donors’ ease by looking for information, customizing, and user-friendly interfaces. The purpose of the launch was to draw more donors to the industry.
Browse All Latest Healthcare and Pharmaceuticals Reports Study@ https://www.acumenresearchandconsulting.com/industry-categories/healthcare-and-pharmaceuticals
Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2162
Download This Premium Research Study – https://www.acumenresearchandconsulting.com/buy-now/0/2162
Would like to place an order or any question, please feel free to contact at firstname.lastname@example.org | +1 407 915 4157
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With a team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.